Razonable RR, O'Horo JC, Hanson SN, Arndt RF, et al. Outcomes of Bebtelovimab Treatment is Comparable to Ritonavir-boosted Nirmatrelvir among High-Risk Patients with Coronavirus Disease-2019 during SARS-CoV-2 BA.2 Omicron Epoch. J Infect Dis 2022 Sep 17. pii: 6702534. doi: 10.1093.
PMID: 36124696